Novaliq
Latest round
- Series E
Last raised
- Mar 2013
Total raised
- $18M
Investors
- 1
About Novaliq
Founded in 2007 in Heidelberg, Germany, Novaliq GmbH specializes in advanced drug delivery systems for ophthalmology and dermatology.Novaliq GmbH primarily develops advanced therapeutic solutions for ophthalmic and dermatological applications. Their flagship product, utilizing proprietary delivery technology, aims to enhance bioavailability and effectiveness while minimizing side effects. The company aims to launch new therapeutic options in ophthalmology and dermatology, targeting expansion into additional European and North American markets by 2025.
Who invested in Novaliq
1 investor across 1 round
See all investors in Novaliq
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Mar 18, 2013
Amount
$18M
Investors
Questions about Novaliq
Who invested in Novaliq?
Novaliq has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novaliq raised?
Novaliq has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Novaliq last raise money?
Novaliq's most recent round on record is a Series E, in Mar 2013.
What does Novaliq do?
Founded in 2007 in Heidelberg, Germany, Novaliq GmbH specializes in advanced drug delivery systems for ophthalmology and dermatology.
Where is Novaliq headquartered?
Novaliq is headquartered in Heidelberg, Germany.
Which VCs invest in companies like Novaliq?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Novaliq's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Novaliq? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.